Sara Naseri
About Sara Naseri
Sara Naseri is the Co-Founder and CEO of Qvin and a Visiting Scholar Scientist at Stanford University School of Medicine. With a background in medicine and business, she advocates for women's health research and collaborates with leading institutions.
Work at Qvin
Sara Naseri serves as Co-Founder and CEO at Qvin, a position she has held since 2014. Under her leadership, Qvin focuses on advancing women's health research, particularly emphasizing the significance of menstrual blood in medical studies. The company operates within the San Francisco Bay Area, where it aims to innovate and address critical gaps in women's health data.
Current Role at Stanford University School of Medicine
Since 2017, Sara Naseri has worked as a Visiting Scholar Scientist at Stanford University School of Medicine. This role allows her to engage in advanced research and collaboration with leading experts in the field. Her work at Stanford complements her efforts at Qvin, particularly in women's health research.
Education and Expertise
Sara Naseri earned her Doctor of Medicine (M.D.) from Aarhus University, completing her studies from 2012 to 2018. She has also participated in various programs, including the Blackbox Connect Program, where she focused on Business Development, and the Singularity University, where she addressed global challenges. Additionally, she is currently studying at Harvard University, specializing in Lab for Integrated Science and Engineering with a focus on the fabrication of microfluidic devices.
Previous Experience
Before her current roles, Sara Naseri held several positions that contributed to her expertise. She was the CEO and Founder of BUCKY'o'ZUN from 2011 to 2014 and served as an Ambassador for Sandbox Network from 2014 to 2017. Additionally, she worked as a Medical Student Researcher at Stanford University School of Medicine from 2015 to 2017, and as a Graduate Student at Singularity University from 2012 to 2014.
Advocacy and Recognition
Sara Naseri is an advocate for closing the gender data gap in medical research. She has presented her work at significant conferences, including the American College of Obstetricians and Gynecologists (ACOG) Annual Conference. Her contributions to women's health research have been recognized in various media outlets, including a feature in Yahoo Lifestyle in 2022 and Bloomberg Markets: Sohn HK 2022.